Q2 closed with large carriers growing operating income 57% on flat-to-declining MA enrollment, while Humana cut its 2026 EPS outlook and announced the exit of roughly 600,000 MA members from additional plans in 2027. The pressure reached providers the same week: Sentara threatened to drop Anthem contracts covering 43,000 MA members over a disputed 6.2% rate increase.
Sentara demands 6.2% rate increase, threatens Anthem network exit
Sentara Health System threatened to exit Anthem contracts covering ~380,000 patients, including ~43,000 MA members, after more than eight months of failed negotiations over a 6.2% rate increase.
Centene staff buyouts priced at $365M in 2026
Centene disclosed a $365M cost for 2026 staff buyouts, signaling a broad internal restructuring at the major payer.
UnitedHealthcare tightens lab reimbursement
UnitedHealthcare implemented stricter reimbursement policies for laboratory tests as part of broader cost controls.
⊕ +2 from Structure , Enforcement
Oscar Health: record H1 profitability, raises full-year outlook
Oscar Health reported record H1 2026 profitability, added nearly 1 million members over 12 months, and raised full-year operating income guidance to $500M–$700M.
Clover Health Q2 revenue +55.6% YoY, raises full-year guidance
Clover Health reported Q2 revenue of $743.2M, up 55.6% year over year, beat estimates, and raised its full-year revenue guidance midpoint to $2.96B.
Alignment Healthcare: 31%+ membership and revenue growth, raised outlook
Alignment Healthcare reported Q2 2026 membership and revenue both growing more than 31% year over year, with management raising its full-year outlook.
Alignment Healthcare under pressure from whistleblower lawsuit
A whistleblower lawsuit prompted law firms to investigate Alignment Healthcare over accounting questions, creating legal overhang on the growth story.
⊕ +1 from Margin
CMS reviews six years of payments in 13 months
CMS initiated a compressed audit schedule requiring payers to respond to six years of payment reviews within a 13-month window.
Risk adjustment becomes a clinical leadership concern
Healthcare leadership outlets are framing risk adjustment as an operational and clinical challenge requiring executive attention and anticipation of friction.
Complete Health settles $14.1M upcoding fraud
DOJ settled a False Claims Act case against Complete Health for $14.1M, covering three years of inflated diagnosis codes submitted to CMS for MA risk adjustment.
⊕ +1 from Structure
Humana up 5.8% after cutting 2026 EPS outlook on strong Q2
Humana reported Q2 revenue of $40.9B and net income of $694M, cut its 2026 EPS outlook, yet stock rose 5.8% on exit and buyback signals.
Q2 2026: 57% operating income growth on flat enrollment
Q2 2026 carrier results show 57% operating income growth for the group on flat-to-declining MA enrollment, driven by UNH and CVS.
CVS triples net income; Aetna MLR recovers 270 bps YoY
CVS Health posted Q2 net income of ~$3B, roughly triple year-ago, with Aetna's medical loss ratio improving 270 basis points year over year.
UNH and CVS grew operating income while shrinking MA membership
Analysis frames UNH and CVS results as proof that selective membership reduction, not growth, is the primary driver of sector profitability improvement.
Humana exits additional MA plans in 2027, affecting ~600K members
Humana announced it will exit additional MA plans in 2027, a move expected to displace roughly 600,000 members.
Margin discipline is structural and permanent, not a cycle to wait out.
Overturned by: realised MA enrolment growing at or above market for the carriers who announced contraction, through two consecutive AEPs
Watching: Watch whether Humana's 600K 2027 exit counties show a measurable MLR improvement in Q3 2026 earnings vs. retained markets. Before November 2026 Q3 earnings calls
Last call: ● TESTING
Penetration keeps rising. Who captures the growth is unresolved.
Watching: Watch whether Oscar and Clover report net MA membership gains in AEP 2027 enrollment counties that overlap with Humana's 2027 exit counties. by February 2027 AEP enrollment reporting
Last call: ● TESTING
Risk adjustment is a cost of participation, not a source of advantage.
Overturned by: any carrier attributing a margin beat to coding or risk-score improvement under V28, in two consecutive quarters
Watching: Watch whether any Tier-1 carrier discloses a reserve or audit-cooperation cost line in Q3 earnings in response to the compressed CMS schedule. Before November 2026 Q3 earnings calls
Last call: ● TESTING
The cost of margin recovery is passed through. Where it lands is unresolved.
Overturned by: margin recovery achieved through genuine cost reduction rather than transfer
Watching: Watch whether Sentara and Anthem resolve their contract dispute before the January lapse date — a network break would confirm providers can no longer absorb payer pricing. by January 1, 2027
Prior authorisation moves from payer discretion to regulated process.
Overturned by: twelve months with no federal rule advancing and penalties staying nominal and unnamed
Star ratings will be restructured, not merely disputed.
Overturned by: a full cycle published, unchallenged, with stable cut points
The independent distribution channel consolidates under financial stress.
Overturned by: a new entrant scaling profitably, or commissions holding through an AEP